Financhill
Back

Black Diamond Therapeutics Stock Predictions

Black Diamond Therapeutics Stock Forecast

  • Is Black Diamond Therapeutics Stock Undervalued?
    The current Black Diamond Therapeutics [BDTX] share price is $2.54. The Score for BDTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BDTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Black Diamond Therapeutics Stock Go Up Next Year?

Data Unavailable

Black Diamond Therapeutics Stock Rating

Data Unavailable

Black Diamond Therapeutics Stock Price History

Is BDTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blackdiamondtherapeutics.com

52-Week Data

52-Week High:
7.66
52-Week Low:
2.16

Prediction Charts

Market Cap:
143.73M
Price in USD:
2.54
Volume:
598.84K
Beta:
2.56

Technical Analysis

SMA50:
3.54
SMA100:
4.60
SMA200:
4.85
52-Wk Change:
8.55%

Stock Predictions

  • Is Black Diamond Therapeutics stock public?
    Yes, Black Diamond Therapeutics is a publicly traded company.
  • What is the Black Diamond Therapeutics stock quote today?
    The Black Diamond Therapeutics stock price is 2.54 USD today.
  • How to buy Black Diamond Therapeutics stock online?
    You can buy Black Diamond Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 3.13 3.25 3.37 3.04
Nov-6 3.28 3.28 3.38 3.11
Nov-7 3.27 3.18 3.36 3.17
Nov-8 3.16 3.29 3.38 3.16
Nov-11 3.33 3.38 3.43 3.22
Nov-12 3.36 3.24 3.44 3.19
Nov-13 3.22 3.13 3.32 3.10
Nov-14 3.12 2.85 3.13 2.84
Nov-15 2.86 2.62 2.86 2.62
Nov-18 2.63 2.50 2.68 2.49
Nov-19 2.53 2.55 2.64 2.48
Nov-20 2.55 2.43 2.56 2.38
Nov-21 2.44 2.43 2.47 2.31
Nov-22 2.43 2.54 2.62 2.40

Black Diamond Therapeutics Earnings

Data Unavailable

Black Diamond Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.

* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.